A new study has uncovered how a surprising player in the immune system, eosinophils, best known for their role in allergies ...

The phase 3 EXHALE-4 study demonstrated that dexpramipexole, an oral small molecule therapy, significantly improved ...

New research shows that eosinophils, immune cells usually linked to allergies, also play a protective role against Candida ...

Discover how glucocorticoid-mediated eosinopoiesis in asthma creates a paradox, influencing relapse, steroid resistance, and ...

In a review of seven studies with 567 patients, the four-food elimination diet -- which cuts milk, wheat, eggs, and ...

The main market opportunities in the eosinophilic esophagitis pipeline include focusing on novel therapeutic approaches, potential development of first-in-class treatments like IRL201104, targeting ...

Positive Results from Clinical Pharmacokinetic Study for the Eosinophilic Esophagitis Specific Formulation with the Drug Candidate AQ280Aqilion today announces positive results from the ARIA-2 ...

Anti-IL5 therapy significantly reduces moderate and severe exacerbations in asthma and COPD, preventing major ...

Mepolizumab significantly reduced healthcare resource utilization, including hospitalizations and emergency department visits, in patients with severe eosinophilic asthma over two years. The treatment ...

Patients who depended on oral corticosteroids to care for their severe asthma experienced improvements in asthma control ...

Health Canada has approved Dupixent® (dupilumab injection) as an add-on maintenance treatment in adult patients with chronic ...

Researchers have discovered a previously unknown immune defense mechanism that protects against dangerous Candida fungal infections, the Hebrew University of Jerusalem said Monday in a statement.